Try our beta test site
1 study found for:    10991971 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
Condition: Chronic Myelogenous Leukemia
Intervention: Drug: Nilotinib

Study has passed its completion date and status has not been verified in more than two years.